SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001193125-18-355317
Filing Date
2018-12-21
Accepted
2018-12-21 08:31:03
Documents
1
Period of Report
2018-12-21
Effectiveness Date
2018-12-21

Document Format Files

Seq Description Document Type Size
1 DEF 14C d678464ddef14c.htm DEF 14C 243062
  Complete submission text file 0001193125-18-355317.txt   244267
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-13467 | Film No.: 181247639
SIC: 8731 Services-Commercial Physical & Biological Research